Clinical Characteristics and Response to Tyrosine Kinase Inhibitors of Patients With Non-Small Cell Lung Cancer Harboring Uncommon Epidermal Growth Factor Receptor Mutations

Chinese Journal of Cancer Research- Hong Kong

doi 10.21147/j.issn.1000-9604.2017.01.03

Full Text

Abstract

Available in

Date

Authors

Publisher

Chinese Journal of Cancer Research

Related search

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non–Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor

JAMA - Journal of the American Medical Association
Medicine
2014English

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Elderly Patients With Advanced Non-Small Cell Lung Cancer

Current Gerontology and Geriatrics Research
GerontologyGeriatrics
2010English

Early Radiographic Response to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations: A Prospective Study

Biomedical Journal
Medicine
2015English

The Treatment of Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

2013English

Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

Estrogen Receptor Β1 Activation Accelerates Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

Oncology Reports
MedicineCancer ResearchOncology
2018English

Identification of Epidermal Growth Factor Receptor Tyrosine-Kinase Mutations in Non-Small Cell Lung Cancer: Testing Platform Matters

Cureus
2020English

Comparison of the Characteristics of Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations and EGFR‑tyrosine Kinase Inhibitor Treatment in Patients With Non‑small Cell Lung Cancer From Different Ethnic Groups

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2020English

Association of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment and EGFR Exon 19 Deletion With Frequency of the T790M Mutation in Non-Small Cell Lung Cancer Patients After Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

OncoTargets and Therapy
OncologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy